BioPlus Acquisition Corp.
260 Madison Avenue
New York, NY 10016
November 30, 2021
VIA EDGAR
United States Securities and Exchange Commission
Division of Corporation Finance
100 F Street, N.E.
Washington, D.C. 20549
Attention: Todd Schiffman
| Re: | BioPlus Acquisition Corp. | |||
| Registration Statement on Form S-1 Filed July 20, 2021, as amended File No. 333-258028 |
Dear Mr. Schiffman:
Pursuant to Rule 461 under the Securities Act of 1933, as amended, BioPlus Acquisition Corp. hereby requests acceleration of effectiveness of the above referenced Registration Statement so that it will become effective at 4:00 p.m. ET on December 2, 2021, or as soon as thereafter practicable.
| Very truly yours, |
| /s/ Ross Haghighat |
| Ross Haghighat |
| Chief Executive Officer and Chief Financial Officer |
| cc: | Latham & Watkins LLP Ellenoff Grossman & Schole LLP |